Business Description
Middle East Healthcare Co
ISIN : SA141H01UKH9
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | 0.29 | |||||
Debt-to-Equity | 1.64 | |||||
Debt-to-EBITDA | 4.56 | |||||
Interest Coverage | 2.28 | |||||
Piotroski F-Score | 9/9 | |||||
Altman Z-Score | 2.37 | |||||
Beneish M-Score | -0.8 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.9 | |||||
3-Year EBITDA Growth Rate | 31.6 | |||||
3-Year EPS without NRI Growth Rate | 29.4 | |||||
3-Year FCF Growth Rate | 57.1 | |||||
3-Year Book Growth Rate | 7.2 | |||||
Future 3-5Y Total Revenue Growth Rate | 5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.23 | |||||
9-Day RSI | 35.66 | |||||
14-Day RSI | 35.67 | |||||
6-1 Month Momentum % | 26.75 | |||||
12-1 Month Momentum % | 118.5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.29 | |||||
Quick Ratio | 1.25 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 25.4 | |||||
Days Sales Outstanding | 268.12 | |||||
Days Payable | 116.25 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -2.72 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 38.23 | |||||
Operating Margin % | 13.18 | |||||
Net Margin % | 6.79 | |||||
FCF Margin % | -1.56 | |||||
ROE % | 12.4 | |||||
ROA % | 3.72 | |||||
ROIC % | 7.51 | |||||
ROC (Joel Greenblatt) % | 8.87 | |||||
ROCE % | 11.92 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 46.48 | |||||
PE Ratio without NRI | 46.48 | |||||
PEG Ratio | 3.55 | |||||
PS Ratio | 3.16 | |||||
PB Ratio | 5.52 | |||||
Price-to-Tangible-Book | 5.63 | |||||
Price-to-Operating-Cash-Flow | 43.86 | |||||
EV-to-EBIT | 30.48 | |||||
EV-to-EBITDA | 19.86 | |||||
EV-to-Revenue | 4.07 | |||||
EV-to-Forward-Revenue | 2.37 | |||||
EV-to-FCF | -262.22 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.63 | |||||
Price-to-Graham-Number | 3.41 | |||||
Earnings Yield (Greenblatt) % | 3.28 | |||||
FCF Yield % | -0.48 | |||||
Forward Rate of Return (Yacktman) % | 9.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Middle East Healthcare Co Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ï·¼) | 2,653.172 | ||
EPS (TTM) (ï·¼) | 1.96 | ||
Beta | 0 | ||
Volatility % | 69.64 | ||
14-Day RSI | 35.67 | ||
14-Day ATR (ï·¼) | 3.559377 | ||
20-Day SMA (ï·¼) | 93.245 | ||
12-1 Month Momentum % | 118.5 | ||
52-Week Range (ï·¼) | 40.3 - 134.4 | ||
Shares Outstanding (Mil) | 92.04 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Middle East Healthcare Co Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Middle East Healthcare Co Stock Events
Event | Date | Price(ï·¼) | ||
---|---|---|---|---|
No Event Data |
Middle East Healthcare Co Frequently Asked Questions
What is Middle East Healthcare Co(SAU:4009)'s stock price today?
When is next earnings date of Middle East Healthcare Co(SAU:4009)?
Does Middle East Healthcare Co(SAU:4009) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |